Jeremy Segal to Protein-Tyrosine Kinases
This is a "connection" page, showing publications Jeremy Segal has written about Protein-Tyrosine Kinases.
Connection Strength
0.251
-
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy. Clin Cancer Res. 2017 Aug 01; 23(15):4212-4223.
Score: 0.128
-
Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget. 2016 Oct 18; 7(42):68833-68841.
Score: 0.124